The CEOs presentation time line Q2 and Q3 on target.
Q1 seem to be done happily with "Validate channel partners" Astra Zeneca , Monaghan, and HGE health and others, Key leadership roles and CTO Mr Geoff Feakes. Search for Mr Feakes showed a lot of interesting relevant history including "myCareTrack" from tunstallhealthcare and others.
"2CY Q2 2021 – Q4 2021Partner scale up in US with revenue traction Scale up of HGE & Monaghan activity Progressive revenue growth Increase penetration in COPD First wave sensors with physiological measures Complete market launch of full range of physiological enabled sensor Limited highly selective ex-US activity"
"3CY 2022Full expansion & platform leverage in US & ex US Accelerated US commercialisation with full portfolio Potential expanded scale up ex-US Assess next wave device development e.g. nebulisers/integrated sensors Potential multi-provider data integration leverage & monetisation"
Hit the targets and the measly 34 million market cap is going to be multiples of that.
The CEOs presentation time line Q2 and Q3 on target. Q1 seem to...
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $7.021M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $11.64K | 642.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 729500 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 206720 | 1 |
View Market Depth
| Last trade - 15.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.8¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 1.8¢ | 1.8¢ | 1.8¢ | 262450 | ||
| Last updated 15.10pm 03/05/2024 ? | |||||
| ADR (ASX) Chart |